Trump Administration Seeks to Remove Arbitrators in Doctor-Insurer Pay Disputes
Federal officials are moving to oust arbitrators handling billing disputes between doctors and insurers, amid concerns over lopsided rulings favoring physicians.
The Trump administration is pushing to remove arbitrators that have been resolving payment disputes between physicians and insurance companies under a federal surprise billing law, according to a New York Times report. The move comes as payouts to doctors have climbed sharply, raising alarms among officials and insurers about the financial trajectory of the arbitration system.
The federal arbitration process was established to shield patients from surprise medical bills by moving billing conflicts directly between providers and insurers. Two companies have been administering those disputes, but the system has drawn scrutiny after one of the arbitrators sided with doctors in an extraordinary 96 percent of cases — a figure that critics argue signals structural imbalance favoring physicians over health plans.
Read more Commerce Dept. Approved Nvidia H200 Chips for Firms With Sanctions Ties →
The lopsided outcomes have contributed to soaring dollar awards for doctors and medical groups, a trend that industry analysts say could ultimately drive up premiums and health care costs for consumers. Insurers have argued that arbitrators are applying the wrong benchmarks when setting payment amounts, pushing settlements far above what the law intended.
The administration's effort to oust the arbitrators represents a significant intervention in a process that was designed to operate at arm's length from direct government influence. Legal and policy experts note that replacing sitting arbitrators mid-process could face procedural and contractual challenges, potentially delaying resolution of thousands of pending billing disputes.
The dispute underscores broader tensions over how the No Surprises Act, which took effect in 2022, is being implemented in practice, with doctors, hospitals, insurers, and federal regulators all contesting the rules of engagement. Continue reading at NYT > Business.
